Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Synthorx announced the appointment of Marcos Milla, Ph.D. as senior vice president of research.
read more
Thursday, September 06, 2018
Synthetic Biologics has entered into an agreement with Cedars-Sinai Medical Center for an investigator-sponsored Phase 2 clinical study of SYN-010.
read more
Synthego Corp., announced the launch of its service partner ecosystem, CRISPR Discovery Partners, designed to accelerate drug discovery by providing a seamless research workflow from CRISPR editing to phenotypic data and downstream services.
read more
Wednesday, October 04, 2023
Synthego, a leading provider of genome engineering solutions, announced the launch of its IND-enabling (INDe) gRNAs, a transformative product offering that revolutionizes the CRISPR-based cell and gene therapy preclinical pipeline.
read more
Synthego announced a partnership with ATCC to provide researchers with an extensive collection of mammalian and mouse cell lines for gene editing applications, including Express Cell Pools to increase speed to results.
read more
Synteract acquired Cu-Tech a dermatology specialist CRO. The two companies have now created a dedicated center of dermatology development.
read more
Wednesday, September 11, 2024
Syntekabio an artificial intelligence (AI)-driven drug development company, announced the appointment of Joonhyuk Choi, former CEO of Target Health, as Head of US Operations.
Joonhyuk brings over 25 years of extensive experience in the ...
read more
Monday, November 30, 2020
After a one-year construction phase, Syntegon Technology inaugurated its new OSD Customer Center in Waiblingen, Germany.
read more
Wednesday, February 11, 2026
Syngene International announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early stage drug discovery programs and platform technologies emerging from the university’s research labs.
read more
As part of the agreement, Syngene will set-up a customized discovery research laboratory to support projects across several therapeutic areas.
read more
Wednesday, January 21, 2026
Syngene International announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning ...
read more
Tuesday, September 06, 2016
Syngene International, one of Asia’s largest R&D focused contract research organizations, has announced the establishment in Bangalore, India, of an integrated, multi-disciplinary drug discovery and development center for Amgen, Inc.
read more
Syngene International, a global contract research, development and manufacturing organization (CRDMO), announced that its newly upgraded biologics facility - Unit 3 - would be operational for clinical and commercial supply in the second half of 2024.
read more
Syngene International announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
read more
Synexus, a Site Management Organization (SMO), dedicated to the recruitment of patients’ and hands-on conduct of clinical trials on behalf of pharmaceutical, biotech and CRO clients, has opened a new Dedicated Clinical Research Site in Frankfurt.
read more